MIDASOLVE Trademark

Trademark Overview


On Tuesday, May 28, 2019, a trademark application was filed for MIDASOLVE with the United States Patent and Trademark Office. The USPTO has given the MIDASOLVE trademark a serial number of 79265537. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by Midatech Limited. The MIDASOLVE trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Nano-particle ingredients, namely, nanoparticle chemical compounds for use in the manufacture of pharmaceuticals, medicines and cosmetics; macrocylic chemicals used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics

Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals and medicines; nano-particles for use as carriers sold as an integral component of pharmaceutical preparations and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles ...

Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in further manufacture of pharmaceuticals, medicines and cosmetics

Scientific research services in the field of nano-particle technology; pharmaceutical and drug research, development and discovery services; drug delivery agent research, development and discovery services; testing and advisory services related to research and product design in the field of nano-particles, macro-cyclic compounds, pharmaceuticals and nano-medicine; nano-particle laboratory research services
midasolve

General Information


Serial Number79265537
Word MarkMIDASOLVE
Filing DateTuesday, May 28, 2019
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6235759
Registration DateTuesday, January 5, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Goods and ServicesNano-particle ingredients, namely, nanoparticle chemical compounds for use in the manufacture of pharmaceuticals, medicines and cosmetics; macrocylic chemicals used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics
Goods and ServicesPharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals and medicines; nano-particles for use as carriers sold as an integral component of pharmaceutical preparations and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles for use as carriers sold as an integral component of medicated cosmetics
Goods and ServicesCustom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in further manufacture of pharmaceuticals, medicines and cosmetics
Goods and ServicesScientific research services in the field of nano-particle technology; pharmaceutical and drug research, development and discovery services; drug delivery agent research, development and discovery services; testing and advisory services related to research and product design in the field of nano-particles, macro-cyclic compounds, pharmaceuticals and nano-medicine; nano-particle laboratory research services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMidatech Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameMidatech Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameMidatech Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, May 2, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 12, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 12, 2021FINAL DISPOSITION PROCESSED
Monday, April 5, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Sunday, October 18, 2020NOTIFICATION PROCESSED BY IB
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 18, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, September 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 27, 2020NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Friday, March 27, 2020SUBSEQUENT FINAL EMAILED
Friday, March 27, 2020SUBSEQUENT FINAL REFUSAL WRITTEN
Thursday, March 26, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 26, 2020FINAL REFUSAL E-MAILED
Thursday, March 26, 2020FINAL REFUSAL WRITTEN
Thursday, March 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 5, 2019REFUSAL PROCESSED BY IB
Friday, September 13, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 13, 2019REFUSAL PROCESSED BY MPU
Tuesday, September 3, 2019APPLICATION FILING RECEIPT MAILED
Sunday, September 1, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 31, 2019NON-FINAL ACTION WRITTEN
Friday, August 30, 2019ASSIGNED TO EXAMINER
Friday, August 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 22, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB